Genome Editing Market By Reports And Data
                     Genome Editing Market Growth, Share, 
Demand and Analysis of Key Players 
Forecasts to 2027
www.reportsanddat
a.com
       Market  Summary
Increasing genomic research across the globe coupled 
with high incidence of target diseases is expected to 
stimulate market growth
Genome Editing Market Size – USD 3.8 billion in 
2018, Market Growth - CAGR of 14.8%, Market Trends 
– Partnerships and research for advanced genetic 
engineering technologies
            M  a Orkuetr  S Aumpmparroyach
The global Genome Editing market is expected to reach USD 10.1 billion by 2026, according to a new report 
by Reports and Data. Genome editing refers to a  genetic engineering method used for insertion, deletion, or 
modification in the genome of any organism. Genome editing has come up as promising tool with wide scale 
application of established genetic engineering technologies such as TALEN and introduction of new methods 
such as CRISPR technology.
The market is driven by the increasing incidence of genetic diseases, favorable funding scenario for research 
& development in the field of genetic engineering, technological advancements in genetic engineering such as 
developments in CRISPR technology, increasing focus of food industry on genetically modified organisms, and 
rising awareness about efficacy as well applications of genetic engineering methods. For instance, globally 
over 175 million hectares of land is used for GM crops production. However, stringent regulatory scenario 
and ethical concerns for gene editing research and applications and concerns among end users regarding use 
of gene alteration therapies are likely to hinder the market growth during the forecast period.
Key participants include Thermo Fisher Scientific Inc., Merck KGaA, GenScript, Horizon Discovery 
Group Plc, Integrated DNA Technologies, Inc, Lonza, New England Biolabs and Sangamo Therapeutics, 
Inc.
Fill in your details to get your hands on an Exclusive Sample of this Report @ 
https://www.reportsanddata.com/sample-enquiry-form/1052
       M   a r kOeut  Sru Ampmparyoach
For the purpose of this report, Reports and Data has segmented the Genetic Editing market on the 
basis of type, application, end user and region:
Type Outlook (Revenue, USD Million, 2016 - 2026)
• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
• Transcription Activator-Like Effector Nucleases (TALEN)
• Zinc Finger Nucleases (ZFN)
• Others
Application Outlook (Revenue, USD Million, 2016 - 2026)
• Animal Genetic Engineering
• Therapeutic Application
• Genetically Modified Organisms
• Plant Genetic Engineering
• Cell Line Engineering
       M   a r kOeut  Sru Ampmparyoach
End User Outlook (Revenue, USD Million, 2016 - 2026)
Pharma-Biotech Companies
Academic Institutes & Research Center
Agrigenomic Companies
Contract Research Organizations
Regional Outlook (Revenue, USD Million, 2016 - 2026)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Do you have questions about the Report or want to inquire about a Discount? Ask our Expert: 
https://www.reportsanddata.com/discount-enquiry-form/1052
       M   a r kOeut  Sru Ampmparyoach
Further key findings from the report suggest
CRISPR market is rising at a high growth rate of 30.9 percent in Asia Pacific followed by North America and 
Europe. Rising application of genetic engineering for therapeutics will drive the demand for the market 
during forecast period across all regions.
The valuation for TALEN market was USD 1.79 billion in 2018 and is expected to grow to USD 2.01 billion by 
2026. Benefits associated with TALEN high degrees of precision and control, is the key factor supporting the 
wide-scale adoption of the technology and consequently contributing to the market growth.
Asia Pacific is expected to witness a CAGR of 15.8 percent in the forecast period. Emerging markets such 
China and Japan are likely to witness high growth
Regional regulatory approval is another key regulatory factor for adoption and growth of genetic editing in 
the region.
Key participants include Thermo Fisher Scientific Inc., Merck KGaA, GenScript, Horizon Discovery 
Group Plc, Integrated DNA Technologies, Inc, Lonza, New England Biolabs and Sangamo Therapeutics, 
Inc.
Read More @ https://www.reportsanddata.com/report-detail/genome-editing-market
   A  b  oOuutr U Aspproach
Reports and Data is a market research and consulting company that provides syndicated research reports, 
customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, 
target and analyze consumer behavior shifts across demographics, across industries and help client’s make 
a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research 
across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We 
consistently update our research offerings to ensure our clients are aware about the latest trends existent in 
the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]